Ken Itrato
Overview
Ken Itrato is a valued and experienced advisor to his clients in addressing a wide range of transactional, financing, and strategic business issues.
He handles a wide range of strategic and funding transactions, including venture capital, private equity, angel financing, and debt and also has a strong mergers and acquisitions practice. As a trusted team member, Ken advises clients with respect to the legal implications of their day-to-day operations, from complex customer and supplier relationships to employment and equity compensation. He effectively counsels on mission-critical licensing and partnering transactions involving core assets, technologies and/or products.
Career & Education
- General corporate and transactional law, AmLaw 50 firmGeneral corporate and transactional law, AmLaw 200 firm
- Cornell University, B.A.
- Georgetown University Law Center, J.D., Order of the Coif
- Massachusetts
Representative Matters
Ken's professional experience encompasses a range of representative matters during his tenure at Faber Daeufer & Itrato PC, prior to his transition to Crowell Life Sciences in 2025. Representative matters include:
- A 25+ year history of equity financings of life sciences organizations including therapeutics companies, biopharmaceutical companies, biotechnology companies, technology companies, and energy companies.
- A 25+ year history of investor-side equity financings on behalf of therapeutics companies, biopharmaceutical companies, biotechnology companies, and technology companies.
- Numerous investments from various venture capital firms and family offices into undisclosed portfolio companies.
- Numerous project financings by private investors on behalf of various companies, and clients by Silicon Valley Bank.
- Numerous strategic transactions, including advising biopharmaceutical, biotechnology, and technology clients across private and public acquisitions, sales or options.